|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-3-4
|
|
pubmed:abstractText |
We report a survey of mesothelioma survival rates with insights into the survival benefit because of pemetrexed. We also studied a potential link between specific single nucleotide polymorphisms of transcobalamin II (TCII) gene and susceptibility to both asbestos and pemetrexed.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1556-1380
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1259-63
|
|
pubmed:meshHeading |
pubmed-meshheading:19546821-Aged,
pubmed-meshheading:19546821-Alleles,
pubmed-meshheading:19546821-Antimetabolites, Antineoplastic,
pubmed-meshheading:19546821-Asbestos,
pubmed-meshheading:19546821-Cohort Studies,
pubmed-meshheading:19546821-Female,
pubmed-meshheading:19546821-France,
pubmed-meshheading:19546821-Genotype,
pubmed-meshheading:19546821-Glutamates,
pubmed-meshheading:19546821-Guanine,
pubmed-meshheading:19546821-Humans,
pubmed-meshheading:19546821-Male,
pubmed-meshheading:19546821-Mesothelioma,
pubmed-meshheading:19546821-Middle Aged,
pubmed-meshheading:19546821-Peritoneal Neoplasms,
pubmed-meshheading:19546821-Polymorphism, Single Nucleotide,
pubmed-meshheading:19546821-Survival Rate,
pubmed-meshheading:19546821-Transcobalamins,
pubmed-meshheading:19546821-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Survey and biological insights of pemetrexed-related therapeutic improvement in mesothelioma: The Nancy Centre of Biological Resources' Mesothelioma Cohort.
|
|
pubmed:affiliation |
The Centre for Biological Resources of Nancy/U724 INSERM, Central Hospital, Nancy, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
